Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant

Emily F. MasonDepartment of Pathology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA; Correspondence[email protected]

Ronald D. BrownDepartment of Pathology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA;

David P. SzetoDepartment of Pathology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA;

Christopher J. GibsonDepartment of Medical-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Yonghui JiaDepartment of Pathology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA;

Elizabeth P. GarciaDepartment of Pathology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA;

Caron A. JacobsonDepartment of Medical-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Paola Dal CinDepartment of Pathology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA;

Frank C. KuoDepartment of Pathology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA;

Geraldine S. PinkusDepartment of Pathology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA;

Neal I. LindemanDepartment of Pathology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA;

Lynette M. ShollDepartment of Pathology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA;

Jon C. AsterDepartment of Pathology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA;

Elizabeth A. MorganDepartment of Pathology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA;

References